Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.

about

Diagnostic Utility of High Sensitivity Troponins for Echocardiographic Markers of Structural Heart Disease.

P2860

Q49805761-3A3A5946-3F5D-4561-B4E3-1360A272EACB

P2860

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.

Item

http://www.wikidata.org/entity/Q36945030

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cardiac Biomarkers and Left Ve ...... tomatic Hemodialysis Patients.

@en

type

Item

label

Cardiac Biomarkers and Left Ve ...... tomatic Hemodialysis Patients.

@en

prefLabel

Cardiac Biomarkers and Left Ve ...... tomatic Hemodialysis Patients.

@en

P1476

Cardiac Biomarkers and Left Ve ...... tomatic Hemodialysis Patients.

@en

P2093

Jivko Andreev

http://www.w3.org/2001/XMLSchema#string

Krasimira Nancheva

http://www.w3.org/2001/XMLSchema#string

Margarit Penev

http://www.w3.org/2001/XMLSchema#string

Reneta Yovcheva Koycheva

http://www.w3.org/2001/XMLSchema#string

Rosen Iliev

http://www.w3.org/2001/XMLSchema#string

Vanya Tsoneva

http://www.w3.org/2001/XMLSchema#string

Vasil Cholakov

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.

Natriuretic peptides in the diagnosis and management of heart failure

Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance.

Cardiac consequences of hypertension in hemodialysis patients.

Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.

Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice

Association of glomerular filtration rate and inflammation with left ventricular hypertrophy in chronic kidney disease patients

Use of cardiac biomarkers in end-stage renal disease.

Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.

P304

59-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3889/OAMJMS.2016.011

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291013029

http://www.w3.org/2001/XMLSchema#string

P698

27275331

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4884254

http://www.w3.org/2001/XMLSchema#string

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.

about

P2860

P2860

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932